These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 165547)

  • 1. Differentiation of nephrotensin from the renin angiotensin system.
    Susic D; Sparks JC
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):958-61. PubMed ID: 165547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of nephrotensin from angiotensin I and II.
    Grollman A; Krishnamurty VS
    Proc Soc Exp Biol Med; 1973 May; 143(1):85-8. PubMed ID: 4349978
    [No Abstract]   [Full Text] [Related]  

  • 3. Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy.
    Marks ES; Bing RF; Thurston H; Russell GI; Swales JD
    Hypertension; 1982; 4(2):238-44. PubMed ID: 6279494
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR; Johnson EM; Heist JF; Marshall GR; Needleman P
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensins lung converting enzyme.
    Loyke HF
    Proc Soc Exp Biol Med; 1973 May; 143(1):82-4. PubMed ID: 4349977
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the renal pressor substance of Grollman is related to angiotensin I.
    Schweikert JR; Carey RM; Liddle GW; Island DP
    Circ Res; 1972 Sep; 31(9):Suppl 2:132-42. PubMed ID: 4341472
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of renal hypertension.
    Brown JJ; Davies DL; Morton JJ; Robertson JI; Cuesta V; Lever AF; Padfield PL; Trust P
    Lancet; 1976 Jun; 1(7971):1219-21. PubMed ID: 58263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of renin suppression by angiotensin II in hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Dluhy RG; Bavli SZ; Solomon HS; Mersey JH
    Circ Res; 1978 Jan; 42(1):46-52. PubMed ID: 618602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
    Thurston H; Swales JD
    Clin Sci Mol Med; 1977 Mar; 52(3):299-304. PubMed ID: 844262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat.
    Morton JJ; Wallace EC
    Clin Sci (Lond); 1983 Apr; 64(4):359-70. PubMed ID: 6186428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining the success or failure of nephrectomy in experimental renal hypertension.
    Koletsky S; Rivera-Velez JM
    J Lab Clin Med; 1970 Jul; 76(1):54-65. PubMed ID: 4316609
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin.
    Knepel W; Meyer DK
    Br J Pharmacol; 1980; 71(1):337-41. PubMed ID: 6162497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade.
    Hiwatari M; Nolan PL; Johnston CI
    Hypertension; 1985; 7(4):547-53. PubMed ID: 2989171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.